<DOC>
	<DOC>NCT02764320</DOC>
	<brief_summary>There are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse. This study will compare the outcomes amongst patients randomized to one of the two treatment strategies.</brief_summary>
	<brief_title>The MOTS (Medication Overuse Treatment Strategy) Trial</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Inclusion Criteria Adults, at least 21 years of age Chronic Migraine diagnosed according to ICHD3beta criteria Medication Overuse diagnosed according to ICHD3beta criteria Willingness to be randomized to either of the two treatment arms Willingness to maintain a headache diary Plan for followup care with the clinician No changes to migraine prophylactic therapy within the 4 weeks prior to randomization. Exclusion Criteria Younger than 21 years of age Headache diagnoses other than chronic migraine with medication overuse; episodic tensiontype headache on 3 or fewer days per month is allowed Not willing to be randomized to either of the treatment arms Not willing to maintain a daily headache diary Not planning on followup care with the clinician In the opinion of the clinician, randomization to either treatment arm would be considered unsafe (ex: pregnancy, immediate discontinuation Prisoners Diminished decisionmaking capacity which in the investigator's opinion would interfere with the person's ability to provide informed consent and complete study procedures.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>